Back

Estimating the generation time for SARS-CoV-2 transmission using household data in the United States, December 2021 - May 2023

Chan, L. Y. H.; Morris, S. E.; Stockwell, M. S.; Bowman, N. M.; Asturias, E.; Rao, S.; Lutrick, K.; Ellingson, K. D.; Nguyen, H. Q.; Maldonado, Y.; McLaren, S. H.; Sano, E.; Biddle, J. E.; Smith-Jeffcoat, S. E.; Biggerstaff, M.; Rolfes, M. A.; Talbot, H. K.; Grijalva, C. G.; Borchering, R. K.; Mellis, A. M.; RVTN-Sentinel Study Group,

2024-10-11 infectious diseases
10.1101/2024.10.10.24315246 medRxiv
Show abstract

BackgroundGeneration time, representing the interval between infection events in primary and secondary cases, is important for understanding disease transmission dynamics including predicting the effective reproduction number (Rt), which informs public health decisions. While previous estimates of SARS-CoV-2 generation times have been reported for early Omicron variants, there is a lack of data for subsequent sub-variants, such as XBB. MethodsWe estimated SARS-CoV-2 generation times using data from the Respiratory Virus Transmission Network - Sentinel (RVTN-S) household transmission study conducted across seven U.S. sites from December 2021 to May 2023. The study spanned three Omicron sub-periods dominated by the sub-variants BA.1/2, BA.4/5, and XBB. We employed a Susceptible-Exposed-Infectious-Recovered (SEIR) model with a Bayesian data augmentation method that imputes unobserved infection times of cases to estimate the generation time. FindingsThe estimated mean generation time for the overall Omicron period was 3.5 days (95% credible interval, CrI: 3.3-3.7). During the sub-periods, the estimated mean generation times were 3.8 days (95% CrI: 3.4-4.2) for BA.1/2, 3.5 days (95% CrI: 3.3-3.8) for BA.4/5, and 3.5 days (95% CrI: 3.1-3.9) for XBB. InterpretationOur study provides estimates of generation times for the Omicron variant, including the sub-variants BA.1/2, BA.4/5, and XBB. These up-to-date estimates specifically address the gap in knowledge regarding these sub-variants and are consistent with earlier studies. They enhance our understanding of SARS-CoV-2 transmission dynamics by aiding in the prediction of Rt, offering insights for improving COVID-19 modeling and public health strategies. FundingCenters for Disease Control and Prevention, and National Center for Advancing Translational Sciences.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
American Journal of Epidemiology
57 papers in training set
Top 0.1%
27.3%
2
Clinical Infectious Diseases
231 papers in training set
Top 0.1%
23.8%
50% of probability mass above
3
JAMA Network Open
127 papers in training set
Top 0.3%
7.2%
4
Annals of Internal Medicine
27 papers in training set
Top 0.1%
6.7%
5
The Journal of Infectious Diseases
182 papers in training set
Top 2%
2.5%
6
The Lancet Infectious Diseases
71 papers in training set
Top 1%
2.5%
7
Influenza and Other Respiratory Viruses
44 papers in training set
Top 0.1%
1.9%
8
Science Advances
1098 papers in training set
Top 16%
1.8%
9
Epidemiology
26 papers in training set
Top 0.2%
1.8%
10
The Lancet
16 papers in training set
Top 0.2%
1.8%
11
PLOS ONE
4510 papers in training set
Top 56%
1.6%
12
BMJ
49 papers in training set
Top 0.6%
1.6%
13
BMC Medicine
163 papers in training set
Top 5%
1.3%
14
Canadian Medical Association Journal
15 papers in training set
Top 0.2%
1.2%
15
Scientific Reports
3102 papers in training set
Top 69%
0.9%
16
BMC Public Health
147 papers in training set
Top 5%
0.8%
17
Emerging Infectious Diseases
103 papers in training set
Top 3%
0.8%
18
The Lancet Digital Health
25 papers in training set
Top 1.0%
0.8%
19
PLOS Computational Biology
1633 papers in training set
Top 23%
0.8%
20
Science
429 papers in training set
Top 19%
0.8%
21
Journal of Medical Virology
137 papers in training set
Top 4%
0.8%
22
Open Forum Infectious Diseases
134 papers in training set
Top 3%
0.8%
23
PNAS Nexus
147 papers in training set
Top 2%
0.8%
24
Philosophical Transactions of the Royal Society B
51 papers in training set
Top 5%
0.8%
25
eLife
5422 papers in training set
Top 57%
0.8%
26
BMC Infectious Diseases
118 papers in training set
Top 6%
0.7%
27
Nature Communications
4913 papers in training set
Top 65%
0.7%
28
JAMA
17 papers in training set
Top 0.5%
0.5%
29
International Journal of Epidemiology
74 papers in training set
Top 3%
0.5%